Showing results (41-50 of 74) with videos related to
Sort By:
Pageof 8
Cancer Cell|November 16, 2010
Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signalingEdwin Chen, Philip A Beer, Anna L Godfrey, et al.Molecular Medicine (Cambridge, Mass.)|May 23, 2007
An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activityEmily C Baechler, Jason W Bauer, Catherine A Slattery, et al.Genes and Immunity|July 21, 2006
Microsatellite typing for DRB1 alleles: application to the analysis of HLA associations with rheumatoid arthritisH-S Lee, W Li, A Lee, et al.Plos Medicine|December 21, 2006
Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosusJason W Bauer, Emily C Baechler, Michelle Petri, et al.Genes and Immunity|November 13, 2004
Fine mapping chromosome 16q12 in a collection of 231 systemic lupus erythematosus sibpair and multiplex familiesC D Gillett, C D Langefeld, A H Williams, et al.Annals of the Rheumatic Diseases|May 2, 2019
Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritisYoshiya Tanaka, Bruno Fautrel, Edward C Keystone, et al.Pediatric Emergency Care|June 3, 2025
Trends in the Management of Complex Febrile Seizures Across Children's HospitalsJames F Buscher, Chelsey R McConnell, Laura A Ortmann, et al.Arthritis Research & Therapy|August 4, 2019
Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulationsIain B McInnes, Nicole L Byers, Richard E Higgs, et al.Diabetes, Obesity & Metabolism|October 6, 2015
Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitusL L Ilag, M A Deeg, T Costigan, et al.Proceedings of the National Academy of Sciences of the United States of America|February 27, 2003
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupusEmily C Baechler, Franak M Batliwalla, George Karypis, et al.Pageof 8